We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.79% | 2.75 | 2.70 | 2.80 | 2.80 | 2.70 | 2.80 | 1,540,809 | 16:02:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 13.09M | -33.29M | -0.0429 | -0.64 | 21.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/8/2020 08:04 | Should read 'deal is struck' | uncleoswald | |
16/8/2020 08:04 | A cautionary question....... With their current cash equal to their current liabilities, what is the likelihood they will need to raise cash before a deal is truck? | uncleoswald | |
14/8/2020 11:02 | i love your price target frrinvest - as i hold over 80k shares i hope you are right - anything £2 plus in short term will be ok with me. The great thing about feraccru is that current there are 2 extremes for treating iron deficiency. The cheap salt based pills that have low absorption and a few side effects or the expensive IV intravenous which is expensive and doesn't address the underlying issue i.e. that someone is struggling to produce sufficient iron on a daily basis. So not only does feraccru sit smack bang in the middle but it can be used in conjunction with both the others. So a doctor prescribes cheap salt based pills for say 2 months. If no improvement put them on feraccru. Severe patients go straight for IV but then get feraccru maybe a month or so afterwards to prevent repeat hospital visits. Some of these patients with underlying health issues may need iron therapy all there lives. Then you have anyone who is pregnant.Iron deficiency is common here so maybe feraccru should be prescribed say in the last 4 months of pregnancy - similar to folic acid early on. Agree massive potential. Good luck all LTH | shandypants2 | |
13/8/2020 21:07 | Looking at the results again, almost comparable with IV in early weeks and then superior in weeks 24, 36 and 52. "At weeks 24, 36 and 52, the mean increases in Hb levels in those patients still being monitored were 2.93 g/dL, 3.16 g/dL and 2.72 g/dL in the Feraccru (R) /Accrufer (R) arm compared with 2.84 g/dL, 2.70 g/dL and 2.79 g/dL in the IV arm." Massive potential imho. Look forward to the deal. | frrinvest | |
13/8/2020 20:50 | Possibility Feraccru/Accrufer could even replace intravenous iron therapy in most cases. The simplicity of taking two oral capsules is very appealing as well as cost effective. In addition, I think the China market is huge so we are looking at potentially a fantastic deal that may surprise us. Lets wait and see, not long to go. p.s. should be around £1.80 before deal and I have now upped my target to £3.50 post deal. | frrinvest | |
13/8/2020 19:16 | Succinct and to the point | kop202 | |
13/8/2020 17:21 | >> 1gw No. | nobbygnome | |
13/8/2020 14:49 | The US deal could come at any time, discussions will have been ongoing for a while and last weeks news will be the catalyst. | mdw1 | |
13/8/2020 14:03 | Interesting price move on no news. I was undecided whether to take the profit or average up - in the end I've bought some more hoping the momentum continues as investors ponder last week's news. As I heard the proactive interview, STX is now waiting on publication of the detailed clinical study report, which is not expected until September/October. Wouldn't it make sense to delay conclusion of a US deal until after that publication? | 1gw | |
13/8/2020 13:53 | News any day now, target £2.50p at least in the short term. | frrinvest | |
13/8/2020 13:38 | Nobby is buying up the last of the free float :) How delightful this sustained surge has been to watch. I do look forward to the RNS list each morning and it must include one with a deal for us soon, you would expect. GLA. | lovewinshatelosses | |
13/8/2020 13:02 | My apologies, they seem to be flowing in now, news imminent? | itshenderz | |
13/8/2020 12:58 | 37k looks to have been bought in a few tranches. Nothing to give here for the mm's, struggling. | itshenderz | |
13/8/2020 12:11 | Good move. Some news coming !? | peachie 74 | |
13/8/2020 12:07 | Long way to go here, sitting tight. | its the oxman | |
13/8/2020 12:06 | Summer time trading All good in the hood here, the only ones crying by the kerbside, are those that were mugged gently sub 100p and above. | ny boy | |
13/8/2020 11:54 | Ooh, it's like watching Frankel - let out another inch of reign ... :) | daveboy1 | |
13/8/2020 11:47 | Doesn't look like my order at 125 will get filled now, think I'll have lunch and look again later - thanks for original tip Nobby - was well down on this last week, but looks much better today :) | boggy | |
13/8/2020 11:47 | Getting to like Thursdays around here - Spread is going up all the time, just like last week. Come on Tim, wiggle those eyebrows if it's a deal ! | daveboy1 | |
13/8/2020 11:46 | Wow, the MMs really are running for cover now.... | nobbygnome | |
13/8/2020 11:40 | Just got another 1000 via spreadbet at the price. Spreadex will let you buy.... | nobbygnome | |
13/8/2020 11:39 | Tried to buy and can't at best, need to leave an order..best laid plans.. | boggy | |
13/8/2020 11:36 | Also watching this, messed up by buying N4P - going to sell out for a loss and buy more of these, hopefully that won't make the price go down..... | boggy | |
13/8/2020 11:35 | Yes Nobby, as my IG index bet is very blue! One to keep buying on the dips as we await US partnership details Onwards & upwards! | ny boy | |
13/8/2020 11:26 | Is no-one else watching this? Got another 2k by spreadbet before the price moved. MMS running for cover... | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions